Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Operating Leases (2019 - 2025)

Utah Medical Products (UTMD) has 7 years of Operating Leases data on record, last reported at $256000.0 in Q2 2025.

  • For Q2 2025, Operating Leases fell 6.91% year-over-year to $256000.0; the TTM value through Jun 2025 reached $256000.0, down 6.91%, while the annual FY2024 figure was $282000.0, 4.41% down from the prior year.
  • Operating Leases reached $256000.0 in Q2 2025 per UTMD's latest filing, down from $282000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $396000.0 in Q4 2021 and bottomed at $256000.0 in Q2 2025.
  • Average Operating Leases over 5 years is $322058.8, with a median of $322000.0 recorded in 2021.
  • Peak YoY movement for Operating Leases: increased 18.21% in 2021, then dropped 14.4% in 2023.
  • A 5-year view of Operating Leases shows it stood at $396000.0 in 2021, then decreased by 13.89% to $341000.0 in 2022, then dropped by 13.49% to $295000.0 in 2023, then dropped by 4.41% to $282000.0 in 2024, then fell by 9.22% to $256000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $256000.0 in Q2 2025, $282000.0 in Q4 2024, and $299000.0 in Q3 2024.